Heilongjiang Zbd Pharmaceutical Co.,Ltd.’s Net Profit Rose 61.2% in First Quarter of 2023

Heilongjiang Zbd Pharmaceutical Co.,Ltd. (黑龙江珍宝岛药业股份有限公司) (603567.SH) reported a net profit of 254.6 million yuan in the first quarter of 2023, up 61.2% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, up 52.7% year-on-year.

At the end of the reporting period, it had 12.1 billion yuan in total assets and 4.7 billion yuan in total liabilities, with a liability-to-asset ratio of 39%.